|
|
|||
| |||||||||||||||||||||||||||||||||||||
Oncology is a relatively young field. Although surgical and radiation treatments for cancer have long histories, the development of effective anticancer drugs began just 50 years ago. David Nathan is among the physicians who have witnessed the entire field unfold, from the earliest experiences with single agents to the current efforts to develop therapies that work at the molecular level. In his new book, he recounts the progress that has been made in the treatment of cancer, with special emphasis on "smart drugs" — agents that target the specific molecular causes of cancer.
Nathan uses the experiences of three patients
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |